Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model
Ryan Thaliffdeen, Anthony Yu, Karen L. Rascati
Topics & Concepts
MedicineMigrainePerspective (graphical)PharmacotherapyCalcitonin gene-related peptideIntensive care medicineMigraine treatmentAlternative medicinePharmacologyPsychotherapistPsychiatryPsychologyInternal medicineComputer scienceArtificial intelligencePathologyNeuropeptideReceptorMigraine and Headache StudiesTraumatic Brain Injury ResearchNicotinic Acetylcholine Receptors Study